Indications and uses
FOR THE PREPARATION OF NORMAL ISOTONIC SOLUTION OF SODIUM CHLORIDE. AS AN ELECTROLYTE REPLENISHER FOR THE PREVENTION OF HEAT CRAMPS DUE TO EXCESSIVE PERSPIRATION. ANY ALTERNATIVE USE AS DIRECTED BY A PHYSICIAN.
GENDOSE - SODIUM CHLORIDE 1 GRAM TABLETS, USP (77333-844)
- Manufacturer
- Gendose Pharmaceuticals, LLC | Neeyaan, LLC
- Effective date
- 2026-10-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- daily-update
- Hydrated at
- 2026-10-09 01:01:55
Label at a glance#
ProductSODIUM CHLORIDE 1 GRAM
Active ingredientSODIUM CHLORIDE
Label structure9 sections
Dosage and administration
TO MAKE AN ISOTONIC SOLUTION OF SODIUM CHLORIDE, DISSOLVE 1 TABLET IN 120 ML (FOUR OUNCES) OF DISTILLED WATER AND USE AS DIRECTED BY A PHYSICIAN. IF USED AS AN ELECTROLYTE REPLENISHER FOR THE PREVENTION OF HEAT CRAMPS DUE TO EXCESSIVE PERSPIRATION TAKE ONE TABLET ORALLY AS DIRECTED BY YOUR PHYSICIAN.
Storage and handling
EACH TABLET CONTAINS: SODIUM 394 MG STORE AT ROOM TEMPERATURE 15° - 30°C (59° - 86°F) PRODUCT DOES NOT CONTAINS ANY INACTIVE INGREDIENTS.
Label contents#
Full prescribing information#
ACTIVE INGREDIENT (IN EACH TABLET)
SODIUM CHLORIDE, USP 1.0 GRAM
PURPOSE
ELECTROLYTE REPLENISHER
USES
- FOR THE PREPARATION OF NORMAL ISOTONIC SOLUTION OF SODIUM CHLORIDE.
- AS AN ELECTROLYTE REPLENISHER FOR THE PREVENTION OF HEAT CRAMPS DUE TO EXCESSIVE PERSPIRATION.
- ANY ALTERNATIVE USE AS DIRECTED BY A PHYSICIAN.
WARNINGS
- DO NOT USE WITHOUT CONSULTING A PHYSICIAN.
- ASK A PHYSICIAN BEFORE USE IF YOU HAVE A SODIUM RESTRICTED DIET DUE TO MULTIPLE ORGAN DISEASES.
- STOP USE AND ASK A PHYSICIAN IF SYMPTOMS OF HEAT CRAMPS CONTINUE FOR MORE THAN 24 HOURS.
- IF PREGNANT OR BREAST FEEDING, ASK A HEALTH PROFESSIONAL BEFORE USE.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- KEEP OUT OF REACH OF CHILDREN. IN CASE OF OVERDOSE, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
DIRECTIONS
- TO MAKE AN ISOTONIC SOLUTION OF SODIUM CHLORIDE, DISSOLVE 1 TABLET IN 120 ML (FOUR OUNCES) OF DISTILLED WATER AND USE AS DIRECTED BY A PHYSICIAN.
- IF USED AS AN ELECTROLYTE REPLENISHER FOR THE PREVENTION OF HEAT CRAMPS DUE TO EXCESSIVE PERSPIRATION TAKE ONE TABLET ORALLY AS DIRECTED BY YOUR PHYSICIAN.
INACTIVE INGREDIENTS
NONE
OTHER INFORMATION
- EACH TABLET CONTAINS: SODIUM 394 MG
- STORE AT ROOM TEMPERATURE 15° - 30°C (59° - 86°F)
- PRODUCT DOES NOT CONTAINS ANY INACTIVE INGREDIENTS.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | DataBar Omni | (01)00377333844107 | GTIN-14: 00377333844107 GTIN-12: 377333844107 UPC-A: 377333844107 EAN-13: 0377333844107 GTIN storage (14 digits): 00377333844107 | 01b LBL_Sodium Chloride_77333-844-10.jpg |
DailyMed Product Concepts#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 77333-844-10 | EA - Each | 77333-844 | 7c802bc8-d6b8-446f-b6cb-d477c423ae61 | 1 | 2023-10-16 |
| 77333-844-25 | EA - Each | 77333-844 | 718ed168-3b55-4ccb-b323-afaf59b3d347 | 1 | 2023-10-16 |
Products#
Every source-derived product name is available through these pages.
- SODIUM CHLORIDE 1 GRAM
- SODIUM CHLORIDE
- CHLORIDE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 77333-844 | 77333-844-25, 77333-844-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2025-07-02 | full-release | 2026-06-01 01:06:33 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 38f735ff-588c-6099-e063-6294a90a2d6d | ff376144-28a1-8811-e053-6394a90aa995 | 2025-07-02 | Warnings | ff376144-28a1-8811-e053-6394a90aa995 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.